Migraine Clinical Trials in Los Angeles

Showing 41-60 of 117 trials

Melatonin for Adolescent Migraine Prevention Study

NCT03150797

This will be a randomized, multi-site double-blind placebo-controlled trial of melatonin (2 different dosing arms) vs. placebo for migraine prevention in adolescents. We intend to enroll approximately 210 participants over 15 months at two sites: UCLA and UCSF. The duration of participation for each participant will be 4 months.

Migraine

Amy Gelfand72 participantsStarted Aug 2017

Los Angeles, California, United States • San Francisco, California, United States

COMPLETEDPhase 3< 1 mile

Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)

NCT04068051

MOVEMENT (Multimechanistic Treatment over Time of Migraine Symptoms) is a Phase 3 study to evaluate the long-term safety of chronic intermittent use of AXS-07 and to assess the effect of AXS-07 on migraine symptoms following repeated treatment of migraine attacks.

Migraine

Axsome Therapeutics, Inc.706 participantsStarted Jul 2019

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +48 more locations

Melatonin for Adolescent Migraine Prevention Study

Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)

Migraine Trials in Other Cities

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Maximizing Outcomes in Treating Acute Migraine

A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine

Randomized Trial in Adult Participants With Acute Migraines

Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition

A Study Investigating the Movement of Lu AG09222 Into, Through, and Out of the Body of Healthy Caucasian, Chinese, and Japanese Participants

Safety and Efficacy in Adult Subjects With Acute Migraines

A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.

A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

Trial in Adult Subjects With Acute Migraines

Efficacy, Tolerability, and Safety of DFN-15

Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention

Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms

Neurolens Headache Study

Other Conditions in Los Angeles